Uzbekistan vs Azerbaijan vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 99% | 71% |
| 2023 | 99% | 71% |
| 2022 | 99% | 71% |
| 2021 | 99% | 66% |
| 2020 | 99% | 61% |
| 2019 | 98% | 78% |
| 2018 | 96% | 77% |
| 2017 | 99% | 80% |
| 2016 | 99% | 81% |
| 2015 | 99% | 84% |
| 2014 | 99% | 85% |
| 2013 | 97% | 86% |
| 2012 | 99% | 86% |
| 2011 | 99% | 88% |
| 2010 | 98% | 89% |
| 2009 | 95% | 85% |
| 2008 | 98% | 79% |
| 2007 | 98% | 75% |
| 2006 | 98% | 69% |
| 2005 | 99% | 67% |
| 2004 | 98% | 67% |
| 2003 | 99% | 67% |
| 2002 | 97% | 66% |
| 2001 | 99% | 68% |
| 2000 | 99% | 67% |
| 1999 | 96% | 68% |
| 1998 | 95% | 67% |
| 1997 | 96% | 66% |
| 1996 | 95% | 65% |
| 1995 | 91% | 64% |
| 1994 | 71% | 60% |
| 1993 | 82% | 49% |
| 1992 | 84% | 52% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 90% | 51% |
| 2023 | 99% | 51% |
| 2022 | 99% | 51% |
| 2021 | 98% | 49% |
| 2020 | 95% | 56% |
| 2019 | 96% | 74% |
| 2018 | 98% | 74% |
| 2017 | 99% | 76% |
| 2016 | 99% | 78% |
| 2015 | 99% | 79% |
| 2014 | 99% | 78% |
| 2013 | 99% | 78% |
| 2012 | 99% | 79% |
| 2011 | 99% | 82% |
| 2010 | 99% | 81% |
| 2009 | 98% | 81% |
| 2008 | 98% | 81% |
| 2007 | 96% | 79% |
| 2006 | 96% | 78% |
| 2005 | 99% | 75% |
| 2004 | 99% | 77% |
| 2003 | 98% | 77% |
| 2002 | 99% | 76% |
| 2001 | 99% | 77% |
| 2000 | 99% | 76% |
| 1999 | 99% | 75% |
| 1998 | 99% | 73% |
| 1997 | 96% | 70% |
| 1996 | 95% | 74% |
| 1995 | 87% | 74% |
| 1994 | 67% | 69% |
| 1993 | 45% | 66% |
| 1992 | 90% | 58% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 88% | 51% |
| 2023 | 99% | 51% |
| 2022 | 99% | 51% |
| 2021 | 98% | 49% |
| 2020 | 95% | 56% |
| 2019 | 96% | 72% |
| 2018 | 98% | 73% |
| 2017 | 99% | 74% |
| 2016 | 99% | 77% |
| 2015 | 99% | 76% |
| 2014 | 99% | 74% |
| 2013 | 99% | 74% |
| 2012 | 99% | 75% |
| 2011 | 99% | 79% |
| 2010 | 99% | 80% |
| 2009 | 98% | 74% |
| 2008 | 91% | 68% |
| 2007 | 99% | 62% |
| 2006 | 98% | 52% |
| 2005 | 99% | 49% |
| 2004 | 99% | 50% |
| 2003 | 99% | 51% |
| 2002 | 62% | 50% |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 99% of children aged 12–23 months in Uzbekistan and 71% in Azerbaijan: 28 percentage points more in Uzbekistan. The third DTP dose reaches 90% in Uzbekistan and 51% in Azerbaijan, 39 points more in Uzbekistan. The third hepatitis B dose reaches 88% in Uzbekistan and 51% in Azerbaijan, 37 points more in Uzbekistan. In 1992, the first measles dose reached 84% in Uzbekistan and 52% in Azerbaijan, 32 percentage points more in Uzbekistan.
Uzbekistan vs Azerbaijan: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 99% (2024) | 71% (2024) |
| DTP3 | 90% (2024) | 51% (2024) |
| HepB3 | 88% (2024) | 51% (2024) |
Uzbekistan and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Azerbaijan and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Uzbekistan and its five neighbors, the latest coverage of the first measles dose is highest in Uzbekistan, at 99%, and lowest in Afghanistan, at 55%; of Azerbaijan and its five neighbors, the latest coverage of the first measles dose is highest in Iran, at 99%, and lowest in Azerbaijan, at 71%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.